为您找到相关结果约500个

你是不是要搜索 期刊Inotuzumab ozogamicin (InO) 联合R-CVP是不适合接受R-CHOP治疗的DLBCL患者可行和有效的一线治疗方案：一项随机、2期UK NCRI试验的结果 点击跳转

Inotuzumab ozogamicin (InO) treatment in patients with relapsed/refractory (R/R) acute lymphoblasticleukemia (ALL): Analysis from INO-VATE by bone marrow blast percentage (BMB%).

Inotuzumab ozogamicin (INO) plus bosutinib (BOS) in R/R PH plus ALL or CML in lymphoid blast phase (CML

Outcomes with inotuzumab ozogamicin (InO) in patients with Philadelphia chromosome-positive (Ph plus) relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL).

DLBCL 1L-What to Expect beyond R-CHOP?

Safety and efficacy of durvalumab with R-CHOP or R-2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label

R-CHOP in DLBCL: priming for success Comment

Inotuzumab Ozogamicin (Besponsa (R)) for Patients with relapsed or refractory acute lymphoblastic Leukemia(r/r ALL)

A phase I trial of dose-adjusted EPOCH plus inotuzumab ozogamicin (InO) in adults with relapsed/refractory(R/R) B lymphoblastic leukemia/lymphoma (B-ALL).

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia (R/R ALL).

A non-randomized risk-adjusted comparison of lenalidomide plus R-CHOP versus R-CHOP for MYC-rearrangedDLBCL patients

randomization to first subsequent induction/salvage therapy (ST) in patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) treated with inotuzumab ozogamicin (InO) in the phase 3 INO-VATE

of minimal residual disease (MRD) status in clinical outcomes of patients with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL) treated with inotuzumab ozogamicin (InO) in the phase 3 INO-VATE

Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly DiagnosedDiffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2

Phase 3 trial of subcutaneous epcoritamab plus R-CHOP versus R-CHOP in patients (pts) with newly diagnoseddiffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2.

RESULTS OF R-CHOP AND R-CHOP

为您找到相关结果约500个

共500条页码: 1/34页15条/页